Home / news / Cann Reaffirms “Buy” Rating for Celgene Corp. (CELG)

Cann Reaffirms “Buy” Rating for Celgene Corp. (CELG)

collected by :Rechard Bernard

follow the latest news of” market news” from different sites to most famous technicals / by 2017-01-02 at 8:29

as mentioned in

Stocks: Celgene Corp. (CELG) Rating Decreased to Buy at the Vetr Inc.

Stocks: Celgene Corp. (CELG) Rating Decreased to Buy at the Vetr Inc.*/

– Vetr downgraded shares of Celgene Corp. (NASDAQ:CELG) from a strong-buy rating to a buy rating in a report issued on Monday morning.They currently have $115.50 price objective on the biopharmaceutical company’s stock.A number of other equities research analysts also recently weighed in on CELG.
.

read more from here

Celgene Corp. (CELG) Downgraded to “Hold” at Zacks Investment Research

Celgene Corp. (CELG) Downgraded to “Hold” at Zacks Investment Research*/

– Zacks Investment Research cut shares of Celgene Corp. (NASDAQ:CELG) from a buy rating to a hold rating in a research report released on Wednesday morning.According to Zacks, “Celgene’s key growth driver, Revlimid, continues to grow on the back of market share gains and increased duration.Other key products – Pomalyst/Imnovid, Abraxane and Otezla – should continue to drive the top line.
.

read more from here

Cann Reaffirms “Buy” Rating for Celgene Corp. (CELG)

Cann Reaffirms “Buy” Rating for Celgene Corp. (CELG)*/

– Cann reissued their buy rating on shares of Celgene Corp. (NASDAQ:CELG) in a research note issued to investors on Tuesday morning.Cann currently has a $141.00 price objective on the biopharmaceutical company’s stock.“Celgene announced today that Japanese regulators have approved Otezla (apremilast) for the treatment of adults with psoriatic arthritis or plaque psoriasis.
.

read more from here

read more
visit us
news

Check Also

cheap stocks

Cheap stocks and its trading in financial markets

Cheap stocks, also known as Cent stocks, are ordinary shares of small public companies traded …